Theratechnologies Inc.
DelistedCIK 1512717fmd_0K8DH72F5C4WKK9SVAPWS5E6B5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Dec 01, 2017 to Nov 30, 2024, 7 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|
| Total revenues | 45 | 63 | 66 | 70 | 80 | 82 | 86 |
| Cost of revenue | 9 | 21 | 21 | 18 | 24 | 20 | 20 |
| Gross profit | 36 | 42 | 45 | 51 | 56 | 62 | 65 |
| Research and development | 8 | 11 | 18 | – | – | – | – |
| Selling, general and administrative | 28 | 35 | 39 | 44 | 57 | 42 | 40 |
| Operating income | (4) | (9) | (18) | (25) | (40) | (11) | 8 |
| Income before taxes | (6) | (12) | (23) | (32) | (47) | (24) | (6) |
| Income tax expense | (1) | – | 0 | 0 | 0 | 0 | 2 |
| Net income from continuing operations | (5) | – | (23) | (32) | (47) | (24) | (8) |
| Net income | (5) | (12) | (23) | (32) | (47) | (24) | (8) |